These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21449724)

  • 1. The influence of Epstein-Barr virus reactivation in patients with Graves' disease.
    Nagata K; Fukata S; Kanai K; Satoh Y; Segawa T; Kuwamoto S; Sugihara H; Kato M; Murakami I; Hayashi K; Sairenji T
    Viral Immunol; 2011 Apr; 24(2):143-9. PubMed ID: 21449724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr Virus Lytic Reactivation Induces IgG4 Production by Host B Lymphocytes in Graves' Disease Patients and Controls: A Subset of Graves' Disease Is an IgG4-Related Disease-Like Condition.
    Nagata K; Hara S; Nakayama Y; Higaki K; Sugihara H; Kuwamoto S; Matsushita M; Kato M; Tanio S; Ishiguro K; Hayashi K
    Viral Immunol; 2018 Oct; 31(8):540-547. PubMed ID: 30222515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivation of persistent Epstein-Barr virus (EBV) causes secretion of thyrotropin receptor antibodies (TRAbs) in EBV-infected B lymphocytes with TRAbs on their surface.
    Nagata K; Nakayama Y; Higaki K; Ochi M; Kanai K; Matsushita M; Kuwamoto S; Kato M; Murakami I; Iwasaki T; Nanba E; Kimura H; Hayashi K
    Autoimmunity; 2015; 48(5):328-35. PubMed ID: 25759125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estradiol Affects Epstein-Barr Virus Reactivation-Induced Thyrotropin Receptor Antibody and Immunoglobulin Production in Graves' Disease Patients and Healthy Controls.
    Hara S; Nagata K; Kumata K; Matsushita M; Kuwamoto S; Kato M; Hayashi K
    Viral Immunol; 2018 Sep; 31(7):486-491. PubMed ID: 30133352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical Epstein-Barr Virus Primary Infection and Lytic Reactivation Induce Thyrotropin Receptor Autoantibodies.
    Tamoto N; Nagata K; Hara S; Nakayama Y; Kuwamoto S; Matsushita M; Kato M; Hayashi K
    Viral Immunol; 2019 Nov; 32(9):362-369. PubMed ID: 31580214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus reactivation in peripheral B lymphocytes induces IgM-type thyrotropin receptor autoantibody production in patients with Graves' disease.
    Nagata K; Hayashi K; Kumata K; Satoh Y; Osaki M; Nakayama Y; Kuwamoto S; Ichihara Y; Okura T; Matsuzawa K; Miake J; Fukata S; Imamura T
    Endocr J; 2023 Jun; 70(6):619-627. PubMed ID: 36908137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr Virus Lytic Reactivation Activates B Cells Polyclonally and Induces Activation-Induced Cytidine Deaminase Expression: A Mechanism Underlying Autoimmunity and Its Contribution to Graves' Disease.
    Nagata K; Kumata K; Nakayama Y; Satoh Y; Sugihara H; Hara S; Matsushita M; Kuwamoto S; Kato M; Murakami I; Hayashi K
    Viral Immunol; 2017 Apr; 30(3):240-249. PubMed ID: 28333576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyrotropin Receptor Antibody (TRAb)-IgM Levels Are Markedly Higher Than TRAb-IgG Levels in Graves' Disease Patients and Controls, and TRAb-IgM Production Is Related to Epstein-Barr Virus Reactivation.
    Kumata K; Nagata K; Matsushita M; Kuwamoto S; Kato M; Murakami I; Fukata S; Hayashi K
    Viral Immunol; 2016 Oct; 29(8):459-463. PubMed ID: 27529807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of Epstein-Barr virus-infected B lymphocytes with thyrotropin receptor antibodies on their surface in Graves' disease patients and in healthy individuals.
    Nagata K; Higaki K; Nakayama Y; Miyauchi H; Kiritani Y; Kanai K; Matsushita M; Iwasaki T; Sugihara H; Kuwamoto S; Kato M; Murakami I; Nanba E; Kimura H; Hayashi K
    Autoimmunity; 2014 May; 47(3):193-200. PubMed ID: 24467196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An investigation on the percentages of TRAb-producing cells in Graves disease].
    Jia W; An Z; Chen D; Wei S
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jan; 34(1):100-3. PubMed ID: 15600195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of Graves' immunoglobulin G: comparison of thyrotropin receptor antibodies in serum and in culture supernatants of lymphocytes transformed by Epstein-Barr virus infection.
    Yokoyama N; Izumi M; Katamine S; Nagataki S
    J Clin Endocrinol Metab; 1987 Feb; 64(2):215-8. PubMed ID: 2878934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr Virus Reactivation-Induced Immunoglobulin Production: Significance on Autoimmunity.
    Nagata K; Hayashi K
    Microorganisms; 2020 Nov; 8(12):. PubMed ID: 33260824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
    Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
    Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of new different assay systems for thyrotropin receptor antibodies with reference to thyroid-stimulating antibodies and thyroid stimulation-blocking antibodies in Graves' disease.
    Hirooka Y; Li C; Takagi J; Gotoh M; Habu S; Yasaka-Nomura T; Ishihara R; Nakasone Y; Nakamura R; Morikawa R; Otake K; Nogimori T; Ishizuki Y
    Int J Clin Pharmacol Res; 2004; 24(4):111-6. PubMed ID: 15754915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Epstein-Barr virus infection in the development of autoimmune thyroid diseases.
    Janegova A; Janega P; Rychly B; Kuracinova K; Babal P
    Endokrynol Pol; 2015; 66(2):132-6. PubMed ID: 25931043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of thyrotropin receptor antibodies in acute phase of infectious mononucleosis due to Epstein-Barr virus primary infection: a case report of a child.
    Nagata K; Okuno K; Ochi M; Kumata K; Sano H; Yoneda N; Ueyama J; Matsushita M; Kuwamoto S; Kato M; Murakami I; Kanzaki S; Hayashi K
    Springerplus; 2015; 4():456. PubMed ID: 26322262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period.
    Carella C; Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Nersita R; Iorio S; Amato G; Braverman LE; Roti E
    Thyroid; 2006 Mar; 16(3):295-302. PubMed ID: 16571093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.